Evidence map›Paper›PMID 40761240›Full record

ArticleFrontiers in oncology2025

SMoFFI-SegFormer: a novel approach for ovarian tumor segmentation based on an improved SegFormer architecture.

Qiuyin Xie, Jianuo Huang, Jingyang Sun, Chenxi Huang, Caixu Xu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qiuyin Xie *Department of Obstetrics and Gynecology, The Third Hospital of Xiamen, Xiamen, Fujian, China.
Jianuo Huang *School of Informatics, Xiamen University, Xiamen, Fujian, China.
Jingyang Sun *School of Informatics, Xiamen University, Xiamen, Fujian, China.
Chenxi HuangSchool of Informatics, Xiamen University, Xiamen, Fujian, China.
Caixu XuGuangxi Key Laboratory of Machine Vision and Intelligent Control, Wuzhou University, Wuzhou, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer remains one of the most lethal gynecological malignancies, posing significant challenges for early detection due to its asymptomatic nature in early stages. Accurate segmentation of ovarian tumors from ultrasound images is critical for improving diagnostic accuracy and patient outcomes. In this study, we introduce SMoFFI-SegFormer, an advanced deep learning model specifically designed to enhance multi-scale feature representation and address the complexities of ovarian tumor segmentation. Building upon the SegFormer architecture, SMoFFI-SegFormer incorporates a novel Self-modulate Fusion with Feature Inhibition (SMoFFI) module that promotes cross-scale information exchange and effectively handles spatial heterogeneity within tumors. Through extensive experimentation on two public datasets-OTU_2D and OTU_CEUS-our model demonstrates superior performance with high overall accuracy, mean Intersection over Union (mIoU), and class accuracy. Specifically, SMoFFI-SegFormer achieves state-of-the-art results, significantly outperforming existing models in both segmentation precision and efficiency. This work paves the way for more reliable and automated tools in the diagnosis and management of ovarian cancer.

Indexed as

deep learningfeature fusionmedical imagingovarian tumor segmentationSMoFFI-SegFormer

Identifiers

PMID40761240
PMCPMC12320497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.